))
SnapCast: Stroke Awareness Month brought to you by Vivistim
Manage episode 415747401 series 2921807
コンテンツは Mike Garrow | David Dansereau によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Mike Garrow | David Dansereau またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Chime In, Send Us a Text Message!
May is Stroke Awareness Month
We’re excited to announce our partnership with Vivistim as part of a Know Stroke Podcast spotlight series for May!
Throughout the month of May we’ll be bringing you two episodes highlighting the breakthrough technology of Vivistim to improve arm and hand function in stroke survivors impacted by chronic ischemic stroke.
On our first episode in this May spotlight series we’ll be speaking with Teresa Jacobson Kimberley, PT, PhD, FAPTA she is the Director of the Rehabilitation Science PhD Program School of Health and Rehabilitation Sciences MGH Institute of Health Professionals. She is also the Director if their Brain Recovery Lab. She's walk us through the science behind vagus nerve stimulation and her research findings with the Vivistim technology.
We'll follow this episode later in May with an interview with Tim Blinten, a young stroke survivor from Massachusetts who will speak to his real world experience with Vivistim.
Thank you again Vivistim for your support in this stroke awareness month spotlight series!
Disclaimer: “The MicroTransponder® Vivistim® Paired VNS™ System is intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment. Do not use if you have had a bilateral or left cervical vagotomy. Risks may include, but are not limited to pain after surgery, hoarseness, bruising, swelling, coughing and throat irritation. While not observed in the Vivistim studies, infection leading to explant is a risk associated with any device surgery. For full safety information, please see www.vivistim.com/safety. Individual results may vary.”
Regulatory note: In 2021, the U.S. Food and Drug Administration (FDA) approved paired vagus nerve stimulation (VNS) for patients with moderate-to-severe upper extremity motor impairments following chronic ischemic stroke.
Show credits:
Music intro credit to Jake Dansereau. Our intro welcome is the voice of Caroline Goggin, a stroke survivor and our first podcast guest! Please listen to her inspiring story on Episode 2 of the podcast.
Connect with Us and Share our Show on Social:
Website | Linkedin | Twitter | YouTube | Facebook
Know Stroke Podcast Disclaimer:
Our podcast and media advertising services are for informational purposes only and do not constitute the practice of medical advice, diagnosis or treatment.
70 つのエピソード
シェア
